Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Adma Biologics Inc’s stock clocked out at $19.94, down -1.92% from its previous closing price of $20.33. In other words, the price has decreased by -$1.92 from its previous closing price. On the day, 1.55 million shares were traded.
Ratios:
To gain a deeper understanding of ADMA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 66.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 52.52. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 6.58. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5. Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 04 ’25 when Lawrence P Guiheen Rev Tr DTD bought 20,000 shares for $20.75 per share.
Guiheen Lawrence P. sold 7,779 shares of ADMA for $158,069 on May 21 ’25. The Director now owns 114,830 shares after completing the transaction at $20.32 per share. On May 22 ’25, another insider, Guiheen Lawrence P., who serves as the Director of the company, sold 1,221 shares for $20.12 each. As a result, the insider received 24,567 and left with 114,830 shares of the company.
Valuation Measures:
As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.62, and their Forward P/E ratio for the next fiscal year is 20.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.36 while its Price-to-Book (P/B) ratio in mrq is 12.74.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $25.67, while it has fallen to a 52-week low of $10.06. The 50-Day Moving Average of the stock is -3.62%, while the 200-Day Moving Average is calculated to be 6.61%.
Shares Statistics:
A total of 238.53M shares are outstanding, with a floating share count of 230.40M. Insiders hold about 3.49% of the company’s shares, while institutions hold 86.39% stake in the company.
